The growth of the global dry eye syndrome treatment market is driven by an increase in the prevalence of dry eye syndrome, the rise in the geriatric population, and the increase in the number of key players.
PORTLAND, Ore., Sept. 29, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Dry Eye Syndrome Treatment Market Drug (Lubricant, Dry Eye Syndrome Drugs and Others), Dosage Form (Eye Drops, Ointments, And Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Providers): Global Opportunity Analysis And Industry Forecast, 2023-2032". According to the report, the global dry eye syndrome treatment market was valued for $4,725.00 million in 2022 and is estimated to reach $9,316.50 million by 2032, exhibiting a CAGR of 7.1% from 2023 to 2032.
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca, occurs when eyes get dry due to lack of lubrication by tears. Dry eye syndrome is more common in people ages 50 and older.
Request Sample of the Report on Dry Eye Syndrome Treatment Market Forecast 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/2807
Prime determinants of growth
An increase in the prevalence of dry eye syndrome and rise in demand for advanced treatment and an increase in the geriatric population drive the growth of the global dry eye syndrome treatment market. However, high cost of the dry eye treatment may restrict the market growth. Moreover, a rise in the number of key players and developing economies presents new opportunities in the coming years.
Report coverage & details:
Report Coverage | Details |
Forecast Period | 2023–2032 |
Base Year | 2022 |
Market Size in 2022 | $ 4.7 billion |
Market Size in 2032 | $ 9.3 billion |
CAGR | 7.1 % |
No. of Pages in Report | 235 |
Segments Covered | Drug, Dosage form, Distribution Channel, and Region. |
Drivers | Rise in prevalence of dry eye syndrome. The rise in the geriatric population. |
Opportunities | Increase in healthcare expenditure and improvement in healthcare infrastructure. |
Restraints | Lack of awareness about dry eye syndrome and high cost of treatment. |
Impact of Covid-19 on Dry Eye Syndrome Treatment Market
- The outbreak of the Covid-19 pandemic had a negative impact on the global dry eye syndrome treatment market, owing to the decrease in the demand for dry eye syndrome treatment and the decline in number of surgeries.
- The companies were more focused on COVID-19 vaccine development.
Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/2807
The dry eye syndrome drugs segment to maintain its leadership status throughout the forecast period.
By drug, the dry eye syndrome drugs segment dominated the market in 2022, and is expected to remain dominant during the forecast period, owing to new product approvals and product launch by key player. In addition, increase in adoption of dry eye syndrome drugs, improving health care services, and rapid economic growth in developing countries further boost the market growth. Lubricant segment held the major CAGR of 7.7% in 2032.
The eye drops segment to maintain its leadership status throughout the forecast period.
Depending on dosage form, the eye drops segment dominated the market in 2022, and is expected to remain dominant during the forecast period, owing to an increase in prevalence of dry eye syndrome and a rise in the adoption of eye drops. Ointments segment held the major CAGR of 8.1% in 2032.
The retail pharmacies segment to maintain its leadership status throughout the forecast period.
By distribution channel, the retail pharmacies segment dominated the market in 2022 and is expected to remain dominant during the forecast period, owing to an increase in the number of retail pharmacies, improvements in the healthcare infrastructure, and increase in the number of dry eye patients. Online providers segment held the major CAGR of 8.1% in 2032.
For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/2807
North America to maintain its dominance by 2032
Based on region, North America has the highest market share, with $2002 million in 2022, and is estimated to reach $3714.5 million by 2032, registering a CAGR of 6.5% during the forecast period. Owing to the presence of well-established healthcare infrastructure. The Asia pacific is projected to register the highest CAGR of 8.4% during the forecast period. High burden of chronic diseases, increase in affordability, and improvements in healthcare access in developing countries such as India and China are the key driving factors that boost the growth of the market in the region.
Leading Market Players: -
- Abbvie
- Viatris
- Novartis AG
- Bausch & Lomb Incorporated
- Sun Pharma
- Novaliq
- Santen Pharmaceutical Co.
- AFT Pharmaceuticals
- Alcon
- Johnson & Johnson
The report provides a detailed analysis of these key players in the global dry eye syndrome treatment market. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Comprehensive Healthcare Industry Research Studies:
Radiodermatitis Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
PET-CT Scanner Device Market - Global Opportunity Analysis and Industry Forecast, 2022-2032
Upper Limb Prosthetics Market - Global Opportunity Analysis and Industry Forecast, 2022-2032
COPD and Asthma Devices Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Vascular Disease Devices Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Oral Cancer Treatment Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Wearable Injectors Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Computed Tomography (CT) Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
Empty Capsules Market - Global Opportunity Analysis and Industry Forecast, 2022–2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/dry-eye-syndrome-treatment-market-to-reach-9-3-billion-globally-by-2032-at-7-1-cagr-allied-market-research-301942747.html
Voltar noticias em Inglês